|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
Netherlands Trial Register |
|
Last refreshed on:
|
28 April 2013 |
|
Main ID: |
NTR363 |
|
Date of registration:
|
12/09/2005 |
|
Primary sponsor: |
|
|
Public title:
|
Randomized controlled trial of psychiatric consultation embedded in continuing education to company physicians for employees with sick leave absence through psychiatric disorders.
|
|
Scientific title:
|
Psychiatric consultation embedded in continuing education to company physicians for employees with sick leave absence through psychiatric disorders. A randomised trial. - BACO Trial |
|
Date of first enrolment:
|
3/10/2005 |
|
Target sample size:
|
400 |
|
Recruitment status: |
recruiting |
|
URL:
|
http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=363 |
|
Study type:
|
intervention |
|
Study design:
|
Randomised: Yes; Masking: None; Control: Active; Group: Parallel; Type: -
|
|
|
Countries of recruitment
|
|
The Netherlands
| | | | | | | |
|
Contacts
|
|
Name:
|
C.M.
Feltz-Cornelis, van der |
|
Address:
|
Trimbos-institute - Netherlands Institute of Mental Health and Addiction, Department of Diagnosis en Treatment,
P.O. Box 725, Da Costakade 45
3500 AS
Utrecht
The Netherlands |
|
Telephone:
|
|
|
Email:
|
cfeltz@trimbos.nl |
|
Affiliation:
|
|
|
|
Name:
|
C.M.
Feltz-Cornelis, van der |
|
Address:
|
Trimbos-institute - Netherlands Institute of Mental Health and Addiction, Department of Diagnosis en Treatment,
P.O. Box 725, Da Costakade 45
3500 AS
Utrecht
The Netherlands |
|
Telephone:
|
|
|
Email:
|
cfeltz@trimbos.nl |
|
Affiliation:
|
|
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Employees with absence from work for a period of at least 6 weeks and no plan for resumption of work within 12 weeks, and a positive screen on either the PHQ or the Whiteley Index.
Exclusion criteria: Insufficient command of Dutch language, negative outcome of PHQ screen, dementia, psychotic symptoms or suicide risk, or the expectation of the company physician of a work related conflict.
Age minimum:
Age maximum:
Gender:
|
|
Health Condition(s) or Problem(s) studied
|
Mental illness, Depressive disorders, Anxiety disorders
|
|
Intervention(s)
|
Company physicians are randomised over 2 conditions:
1. the intervention group and
2. care-as-usual group.
All company physicians in both conditions receive continuing education and follow a training programme targeted at diagnosis and treatment of depressive disorder and anxiety disorder.
In the intervention group patients of company physicians receive psychiatric consultation as well, resulting in an individually tailored diagnosis and treatment advice.
These psychiatric consultation are enbedded in the continuing education to company physicians.
|
|
Primary Outcome(s)
|
|
Reduction of symptoms as measured with the PHQ and quality of life as measured with the SF-20.
|
|
Secondary Outcome(s)
|
|
Number of complaints, general functioning, fatigue, duration of sick leave.
|
|
Secondary ID(s)
|
|
ISRCTN86722376
|
|
N/A
|
|
Source(s) of Monetary Support
|
|
STECR Alladin Program, ArboNed, ArboUnie
|
|